| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 56 |
| 1 | GALCANEZUMAB-GNLM | 38 |
| 2 | INSULIN LISPRO | 18 |
| 3 | ALBUTEROL SULFATE | 10 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 10 |
| 5 | RIVASTIGMINE | 10 |
| 6 | ESOMEPRAZOLE | 9 |
| 7 | FOLIC ACID | 9 |
| 8 | PREDNISONE | 8 |
| 9 | ROPINIROLE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULFACETAMIDE SODIUM, SULFUR | 1 | 0.0087 |
| 1 | ACORAMIDIS HYDROCHLORIDE | 1 | 0.0027 |
| 2 | SCOPOLAMINE | 8 | 0.0022 |
| 3 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| 4 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 5 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 6 | GALCANEZUMAB-GNLM | 38 | 0.0012 |
| 7 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0011 |
| 8 | MONOMETHYL FUMARATE | 1 | 0.0011 |
| 9 | METHYLNALTREXONE BROMIDE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 57 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 56 |
| 2 | Insulin Analog [EPC] | 21 |
| 3 | Corticosteroid [EPC] | 15 |
| 4 | Proton Pump Inhibitor [EPC] | 13 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 7 | Anticholinergic [EPC] | 10 |
| 8 | Cholinesterase Inhibitor [EPC] | 10 |
| 9 | Vitamin B12 [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Anticholinergic [EPC] | 10 | 0.0006 |
| 2 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 3 | Cholinesterase Inhibitor [EPC] | 10 | 0.0005 |
| 4 | Nonergot Dopamine Agonist [EPC] | 8 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |
| 9 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |